Cargando…

Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis

CD44 is a marker of cancer stem-like cells in renal cell carcinoma (RCC). However, the prognostic value of CD44 in RCC remains controversial. This study evaluated the correlation of CD44 expression with the clinicopathological features of RCC through a meta-analysis. We systematically searched PubMe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xintao, Ma, Xin, Chen, Luyao, Gu, Liangyou, Zhang, Yu, Zhang, Fan, Ouyang, Yun, Gao, Yu, Huang, Qingbo, Zhang, Xu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541415/ https://www.ncbi.nlm.nih.gov/pubmed/26287771 http://dx.doi.org/10.1038/srep13157

Ejemplares similares

MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis
por: Gu, Liangyou, et al.
Publicado: (2015)

Prognostic role of urinary collecting system invasion in renal cell carcinoma: a systematic review and meta-analysis
por: Chen, Luyao, et al.
Publicado: (2016)

Prognostic and Clinicopathological Significance of Survivin Expression in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
por: Xie, Yongpeng, et al.
Publicado: (2016)

Prognostic value of a systemic inflammatory response index in metastatic renal cell carcinoma and construction of a predictive model
por: Gu, Liangyou, et al.
Publicado: (2016)

Prognostic value of high IMP3 expression in solid tumors: a meta-analysis
por: Chen, Luyao, et al.
Publicado: (2017)

The Association of Platelet Count with Clinicopathological Significance and Prognosis in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
por: Gu, Liangyou, et al.
Publicado: (2015)

Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Localized and Advanced Prostate Cancer: A Systematic Review and Meta-Analysis
por: Tang, Lu, et al.
Publicado: (2016)

Postoperative Adjuvant Sorafenib or Sunitinib for Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus: a Prospective Cohort Study
por: Gu, Liangyou, et al.
Publicado: (2017)

Prognostic and clinicopathological role of high Ki-67 expression in patients with renal cell carcinoma: a systematic review and meta-analysis
por: Xie, Yongpeng, et al.
Publicado: (2017)

Prognostic Value of Clinical and Pathological Features in Chinese Patients with Chromophobe Renal Cell Carcinoma: A 10-Year Single-Center Study
por: Xie, Yongpeng, et al.
Publicado: (2017)

The Impact of Diabetes Mellitus on Renal Cell Carcinoma Prognosis: A Meta-Analysis of Cohort Studies
por: Chen, Luyao, et al.
Publicado: (2015)

Prognostic role of lymphocyte to monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis
por: Gu, Liangyou, et al.
Publicado: (2016)

Phosphatase and tensin homolog (PTEN) expression on oncologic outcome in renal cell carcinoma: A systematic review and meta-analysis
por: Tang, Lu, et al.
Publicado: (2017)

MicroRNAs with prognostic significance in bladder cancer: a systematic review and meta-analysis
por: Xie, Yongpeng, et al.
Publicado: (2017)

LncRNAs act as prognostic and diagnostic biomarkers in renal cell carcinoma: a systematic review and meta-analysis
por: Chen, Jianwen, et al.
Publicado: (2016)

Influence of tumor size on oncological outcomes of pathological T3aN0M0 renal cell carcinoma treated by radical nephrectomy
por: Chen, Luyao, et al.
Publicado: (2017)

Prognostic value of preoperative inflammatory response biomarkers in patients with sarcomatoid renal cell carcinoma and the establishment of a nomogram
por: Gu, Liangyou, et al.
Publicado: (2016)

Prognostic Significance of Hypoxia-Inducible Factor Expression in Renal Cell Carcinoma: A PRISMA-compliant Systematic Review and Meta-Analysis
por: Fan, Yang, et al.
Publicado: (2015)

Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma
por: Ma, Xin, et al.
Publicado: (2015)

The clinicopathological and prognostic value of CD44 expression in bladder cancer: a study based on meta-analysis and TCGA data
por: Hu, Yu, et al.
Publicado: (2020)

Prognostic value of neutrophil-to-lymphocyte ratio in urothelial carcinoma of the upper urinary tract and bladder: a systematic review and meta-analysis
por: Li, Xintao, et al.
Publicado: (2016)

Prognostic and Predictive Values of Subcellular Localisation of RET in Renal Clear-Cell Carcinoma
por: Wang, Lei, et al.
Publicado: (2016)

The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis
por: Wang, Zhenpeng, et al.
Publicado: (2019)

Prognostic value of CD44 expression in patients with hepatocellular carcinoma: meta-analysis
por: Luo, Yangkun, et al.
Publicado: (2016)

miR-363 suppresses the proliferation, migration and invasion of clear cell renal cell carcinoma by downregulating S1PR1
por: Xie, Yongpeng, et al.
Publicado: (2020)

Role of presurgical targeted molecular therapy in renal cell carcinoma with an inferior vena cava tumor thrombus
por: Peng, Cheng, et al.
Publicado: (2018)

Sarcomatoid variant urothelial carcinoma of the bladder: a systematic review and meta-analysis of the clinicopathological features and survival outcomes
por: Gu, Liangyou, et al.
Publicado: (2020)

Reduced E-cadherin expression is correlated with poor prognosis in patients with bladder cancer: a systematic review and meta-analysis
por: Xie, Yongpeng, et al.
Publicado: (2017)

The prognostic value and immunological role of CD44 in pan-cancer study
por: Chen, Shaoyong, et al.
Publicado: (2023)

Correction: Reduced E-cadherin expression is correlated with poor prognosis in patients with bladder cancer: a systematic review and meta-analysis
por: Xie, Yongpeng, et al.
Publicado: (2019)

Prevalence and Characterization of Somatic Mutations in Chinese Aldosterone-Producing Adenoma Patients
por: Wang, Baojun, et al.
Publicado: (2015)

Prognostic value of CD133(+) CD54(+) CD44(+) circulating tumor cells in colorectal cancer with liver metastasis
por: Fang, Chao, et al.
Publicado: (2017)

The prognostic value of CD44 isoform expression in endometrial cancer.
por: Tempfer, C., et al.
Publicado: (1998)

Prognostic value of CD44v6 expression in breast cancer: a meta-analysis
por: Qiao, Guang-Lei, et al.
Publicado: (2018)

Androgen receptor increases hematogenous metastasis yet decreases lymphatic metastasis of renal cell carcinoma
por: Huang, Qingbo, et al.
Publicado: (2017)

Prognostic value of CD44v9 expression in human cancers: A systematic review and meta-analysis
por: Zeng, Li, et al.
Publicado: (2020)

Prognostic significance of CD44V6 expression in osteosarcoma: a meta-analysis
por: Zhang, Yunyuan, et al.
Publicado: (2015)

RhoB Acts as a Tumor Suppressor That Inhibits Malignancy of Clear Cell Renal Cell Carcinoma
por: Chen, Weihao, et al.
Publicado: (2016)

Meta-Analysis of Prognostic and Clinical Significance of CD44v6 in Esophageal Cancer
por: Hu, Bangli, et al.
Publicado: (2015)

Prognostic Value of CD44 and Its Isoforms in Advanced Cancer: A Systematic Meta-Analysis With Trial Sequential Analysis
por: Han, Susu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8elhhr51tai461nv0sakskfei8